top of page
News, Events and Updates
Search
Novel Anti-Seizure Compound ANAVEX 2-73 a Sigma-1 Receptor Agonist in Multiple Seizure Models
Dec 11, 2015
Third Annual MHPAEA Business Roundtable
Dec 8, 2015
ICV Manhattan 2015
Dec 8, 2015
American Epilepsy Society Annual Meeting
Dec 8, 2015
Anavex to Present at Third Annual MHPAEA Business Roundtable in Washington, D.C.
Dec 7, 2015
Anavex Expands Management Team
Dec 2, 2015
Independent Research Describes ANAVEX 3-71 as Potent Cognitive Enhancer in Alzheimer's Disease Model
Nov 30, 2015
New Exploratory Alzheimer's Drug ANAVEX 2-73: Assessment of Safety and Cognitive Performance
Nov 27, 2015
Anavex Announces Executive Overseeing Regulatory Affairs
Nov 25, 2015
Anavex to Present at American Epilepsy Society Annual Meeting ANAVEX 2-73 Shows Anti-Seizure Effects
Nov 19, 2015
Anavex Announces Preparation of Regulatory Filings based on Guidance From the FDA
Nov 18, 2015
32
33
34
35
36
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
